The treatment of tumors has been a wide concern by a large number of scientific researchers. Combining magnetic resonance imaging (MRI) with photothermal therapy (PTT) enables cancer theranostics to be more efficient and accurate. Herein, we synthesized CuS@BSA nanoparticles with an average grain diameter of about 16.5 nm through a facile one-pot eco-friendly and user-friendly strategy and it was found to have strong near-infrared absorption property and magnetic resonance imaging ability so that it can be utilized as a multifunctional agent for cancer theranostic. The in vitro toxicity study showed that CuS@BSA nanoparticles with low toxicity could kill cancer cells with the 980 nm NIR laser effectively. Furthermore, they exhibit a certain value of relaxivity (r 1 = 0.26 mM–1·s–1) compared to that of clinically widely used reagent Magnevist (r 1 = 3.13 mM–1·s–1). The resulting product of CuS@BSA nanoparticles with their magnetic resonance imaging (MRI) and photothermal therapeutic capabilities could represent a kind of potential candidate for cancer theranostics.

The ultrasmall sizes of nanoparticles have attracted significant attention for potential applications in the fields of catalysis and nanomedicine. Herein, we reported on the green preparation and X-ray computed tomography (CT) imaging of ultrasmall bimetallic bovine serum albumin-directed gold–silver (Au–Ag@BSA) nanoparticles (2–4 nm) using BSA as a stabilizing and template-directed agent. Further, the effects of synthesis conditions were systematically explored to prepare products by adjusting the different molar ratios of Au/Ag. The resulting Au–Ag@BSA nanoparticles exhibited the spherical shape, well-dispersed ability, as well as long-term room-temperature stability. The cytotoxicity effects of Au–Ag@BSA nanoparticles on A549 and MCF-7 cells were compared with those of individual Ag nanoparticles, and the results indicated a lower cytotoxicity effect by Au–Ag@BSA nanoparticles. Furthermore, the in vivo toxicity of Au–Ag@BSA nanoparticles was investigated in the early stage zebrafish embryos. The results indicate that there are not any obvious changes of survival and hatching percentages at multiple growth stages (4–120 hpf) even with a high level of Au–Ag@BSA nanoparticles (up to 80 mM), revealing good biocompatibility. Interestingly, a rational design of the Au/Ag molar ratio (3:2) surprisingly possessed enhanced CT performance compared to the performance of the Au nanoparticles and iohexol. Accordingly, this study highlights a new prospect in the green preparation of ultrasmall alloy nanomaterials with good biocompatibility and will be of great interest in developing CT contrast agent, catalyst, as well as drug delivery carrier.

No abstract

No abstract

No abstract